New research shows prenatal PFAS exposure increases maternal insulin resistance and beta-cell dysfunction, with EU regulators proposing stricter limits as clinical trials explore interventions. June 2...
Advanced retinal imaging combined with explainable AI achieves 87.25% accuracy in detecting metabolic syndrome, offering non-invasive screening that could revolutionize preventive healthcare globally....
Breakthrough research demonstrates how vision transformers analyze eye scans to predict metabolic dysfunction years before symptoms emerge, with 89% accuracy in recent trials. Advanced AI systems now ...
A July 2024 study in *Nutrition Research* demonstrates konjac glucomannan gel reduces LDL cholesterol by 27% in high-fat-diet mice, highlighting its potential for metabolic health interventions. Groun...
Emerging research highlights intermittent fasting’s paradoxical effects – improved metabolic markers versus increased cardiovascular mortality risks, prompting calls for personalized appro...
Recent studies reveal curcumin’s efficacy in reducing blood glucose and improving cardiovascular health, supported by enhanced bioavailability formulations and updated regulatory guidelines for ...
New research reveals frozen gel konjac glucomannan outperforms other forms in boosting gut microbiota diversity while effectively regulating glucose and lipid metabolism. Cutting-edge studies demonstr...
Emerging research shows prenatal PFAS exposure significantly increases risks of gestational diabetes and long-term metabolic disorders through beta cell disruption. Groundbreaking 2024 studies demonst...
New research reveals how modified forms of konjac glucomannan differentially impact glucose and lipid metabolism in obesity through gut microbiota alterations. Cutting-edge studies demonstrate konjac ...
Recent research reveals how intermittent fasting protocols interact with circadian rhythms to improve insulin sensitivity, gut microbiome diversity, and metabolic markers beyond weight loss. Emerging ...
